Stay updated on Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-05-01T04:22:39.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The webpage has updated its date references, adding new dates in April 2025 while removing older dates from February 2025.
    Difference
    0.3%
    Check dated 2025-04-23T19:38:30.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has been updated to include new information about Medullary Thyroid Cancer and its associated study, while significant details regarding the study's purpose and eligibility criteria have been removed.
    Difference
    12%
    Check dated 2025-04-16T14:29:23.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 27, 2025.
    Difference
    0.2%
    Check dated 2025-04-09T09:17:06.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version release, moving from v2.14.2 to v2.14.3, and the last update date has changed from February 27, 2025, to March 25, 2025.
    Difference
    0.2%
    Check dated 2025-04-01T23:19:43.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The webpage has updated its date references to include new dates in February 2025, while older dates have been removed.
    Difference
    1.0%
    Check dated 2025-03-03T23:56:35.000Z thumbnail image

Stay in the know with updates to Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.